Ability to Access Community-based Needle-syringe Programs and Injecting Behaviors Among Drug Users: a Cross-sectional Study in Hunan Province, China
Overview
Psychiatry
Affiliations
Background: Needle-syringe exchange programs (NSPs) have been substantially rolled-out in China since 2002. Limited studies reported effectiveness of NSPs in a Chinese setting. This study aimed to assess the association between accessibility to NSPs and drug-use risk behaviors of IDUs by investigating primary (self-reported) data of IDUs recruited from NSP sites, community settings and mandatory detoxification centers (MDCs) in Hunan province, China.
Methods: A cross-sectional survey was conducted in Hunan province in 2010. IDU recruits participated in a face-to-face interview to provide information related to their ability to access NSPs, demographic characteristics, and injecting behaviors in the past 30 days.
Results: Of the total 402 participants, 35%, 14% and 51% participants indicated low, medium and high ability to access NSPs in the past 30 days, respectively. A significantly higher proportion of IDUs (77.3%) from the high-access group reported ≤2 injecting episodes per day compared with medium- (46.3%) and low-access (58.8%) groups. Only 29.0% of high-access IDUs re-used syringes before disposal in the past 30 days, significantly lower than those in the medium- (43.1%) and low-access (41.3%) groups. Reported levels of needle/syringe sharing decreased significantly as the ability to access NSPs increased (16.3%, 12.7% and 2.5% in the low, medium and high access groups, respectively). Ninety percent of IDUs recruited from MDCs had low ability to access NSPs.
Conclusions: Increased NSP accessibility is associated with decreased levels of injecting frequency, repetitive use and sharing of injecting equipment among Chinese IDUs. Mandatory detention of IDUs remains as a major barrier for IDUs to access NSPs in China.
Tookes H, Bartholomew T, Soto Sugar S, Plesons M, Bluthenthal R, Wenger L Int J Drug Policy. 2023; 123:104289.
PMID: 38071932 PMC: 10878422. DOI: 10.1016/j.drugpo.2023.104289.
Zanoni B, Milford C, Sithole K, Mosery N, Wilson M, Bosman S PLoS One. 2023; 18(5):e0281030.
PMID: 37172026 PMC: 10180682. DOI: 10.1371/journal.pone.0281030.
Yeh P, Yang X, Kennedy C, Armstrong K, Fonner V, Sherryn AIDS Behav. 2023; 27(10):3306-3331.
PMID: 37046029 PMC: 10524190. DOI: 10.1007/s10461-023-04051-x.
Zhang B, Yan X, Li Y, Zhu H, Liu Z, Lu Z Harm Reduct J. 2021; 18(1):63.
PMID: 34118933 PMC: 8199561. DOI: 10.1186/s12954-021-00511-6.
Zhang B, Yan X, Li Y, Liu Z, Lu Z, Jia Z Int J Environ Res Public Health. 2020; 17(15).
PMID: 32751337 PMC: 7431999. DOI: 10.3390/ijerph17155483.